15-8 |
Amoxicillin |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
15-8 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Amoxicillin Islt MLC |
|
|
|
Y |
|
Amox; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bristamox; c204; c6; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Moxalin; Point in time; Polymox; QNT; Quan; Quant; Quantitative; Random; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
150-3 |
Cephalexin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Cephalexin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
150-3 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Cephalexin Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadine; Disk diffusion; GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Keflex; Kirby-bauer; Losporal; Palitrex; Point in time; Random; Salitex; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.21 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1500-8 |
Glucose^1H post 0.05-0.15 U insulin/kg IV post 12H CFst |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1500-8 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 1h p U/kg Ins IV SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p U/kg Ins IV; 60 min; 60 minutes; 60M; 60min; After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p 12h fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15000-3 |
Thyrotropin^pre dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
15000-3 |
|
|
|
|
Observation |
|
|
|
0 |
TSH pre TRH IV SerPl-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; pre TRH; pre TRH IV; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.73 |
1.0k |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
15001-1 |
Xylose^1H post 25 g xylose PO |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
15001-1 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 1h p 25 g Xyl PO SerPl-sCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 25 g Xyl PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 25 g Xyl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylose absorption test |
2.34 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
15002-9 |
Xylose^2H post 25 g xylose PO |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
15002-9 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 2h p 25 g Xyl PO SerPl-sCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 25 g Xyl PO; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 25 g Xyl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylose absorption test |
2.34 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
15003-7 |
11-Hydroxyandrosterone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15003-7 |
|
|
|
|
Both |
|
|
|
0 |
11OH-Androst 24h Ur-sRate |
|
|
|
Y |
|
1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15004-5 |
11-Hydroxyetiocholanolone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15004-5 |
|
|
|
|
Both |
|
|
|
0 |
11OH-Etioch 24h Ur-sRate |
|
|
|
Y |
|
1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15005-2 |
11-Ketoandrosterone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
11-Ketoandrosterone [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15005-2 |
|
|
|
|
Both |
|
|
|
0 |
11Ketoandros 24h Ur-sRate |
|
|
|
Y |
|
1 day; 11Ketoandros; 24 hours; 24HR; Chemistry; Ketoandrost; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15006-0 |
11-Ketoetiocholanolone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
15006-0 |
|
|
|
|
Both |
|
|
|
0 |
11Ketoetioch 24h Ur-sRate |
|
|
|
Y |
|
1 day; 11Ketoetioch; 24 hours; 24HR; Chemistry; Ketoetiochol; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
15007-8 |
2,3-Diphosphoglycerate |
SCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
15007-8 |
|
|
|
|
Both |
|
|
|
0 |
2,3DPG RBC-sCnc |
|
|
|
Y |
|
2,3DPG; 2,3-DPG; Biphosphoglycerate; Chemistry; DPG; Erythrocytes; II; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
15008-6 |
3-Alpha-Androstanediol glucuronide |
SCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
15008-6 |
|
|
|
|
Both |
|
|
|
0 |
3A-diol G Ser-sCnc |
|
|
|
Y |
|
3A-diol G; 3-alpha-diol G; Alfa; Chemistry; Gluc; Glucouronide; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
15009-4 |
5-Hydroxyindoleacetate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
5-Hydroxyindoleacetate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
15009-4 |
|
|
|
|
Both |
|
|
|
0 |
5OH-indoleacetate Ur-sCnc |
|
|
|
Y |
|
5HIA; 5HIAA; 5-HIAA; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Chemistry; Hydroxyindoacet; Level; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serotonin metabolite; Substance concentration; Tumor marker; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
1501-6 |
Glucose^1H post 100 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL.ROUTINE |
|
1501-6 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 1h p 100 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 100 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
Changed Class from "CHAL" to "CHAL.ROUTINE" |
0 |
15010-2 |
Aldosterone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
15010-2 |
|
|
|
|
Both |
|
|
|
0 |
Aldost Ur-sCnc |
|
|
|
Y |
|
Chemistry; Endocrine; Endocrinology; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
15011-0 |
Aldosterone^supine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Moles/volume] in Serum or Plasma --supine |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
15011-0 |
|
|
|
|
Both |
|
|
|
0 |
Aldost sup SerPl-sCnc |
|
|
|
Y |
|
CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Lying; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
Release 2.68: CLASS: Place supine and standing terms consistently in CHAL class |
0 |
15012-8 |
Aldosterone^upright |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Moles/volume] in Serum or Plasma --upright |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
15012-8 |
|
|
|
|
Both |
|
|
|
0 |
Aldost upr SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Endocrine; Endocrinology; Erect; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Standing; Substance concentration; Upr; Uprt |
2.7 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
15013-6 |
Alkaline phosphatase.bone/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15013-6 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Bone CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Bone; ALP-2; AP; B-ALP; BALPase; BAP; Catalytic Fraction; Chemistry; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15014-4 |
Alkaline phosphatase.intestinal/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15014-4 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Intest CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.GI; Alkaline phosphatase.total; ALKP; ALP; ALP Intest; ALP-3; ALPI; AP; Catalytic Fraction; Chemistry; IAP; Intest; Intestine; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15015-1 |
Alkaline phosphatase.liver/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15015-1 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Liver CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Liver; ALP-1; AP; Catalytic Fraction; Chemistry; Hepatology; Liver; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15016-9 |
Alkaline phosphatase.placental/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15016-9 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Plac CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Plac; AP; Catalytic Fraction; Chemistry; Percent; Phos; Phosphtase; Pl; Placent; Placenta; Placntl; PLAP; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15017-7 |
Alkaline phosphatase.regan/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15017-7 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Regan CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Regan; AP; Catalytic Fraction; Chemistry; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15018-5 |
Alkaline phosphatase.renal/Alkaline phosphatase.total |
CFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15018-5 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Renal CFr SerPl |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.kidney; Alkaline phosphatase.total; ALKP; ALP; ALP Renal; AP; Catalytic Fraction; Chemistry; Kidney; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15019-3 |
Alpha-1-Fetoprotein |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
15019-3 |
|
|
|
|
Both |
|
|
|
0 |
AFP Amn-sCnc |
|
|
|
Y |
|
A1; AF; AFAFP; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Feto; Gyn; Gynecology; i; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tumor marker |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
1502-4 |
Glucose^1H post 100 g glucose PO |
MCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHAL |
|
1502-4 |
|
|
|
|
|
|
|
|
0 |
Deprecated Glucose 1H p 100 g Glc PO Ser |
|
|
|
|
|
1 hour; 1.0Hr; 1h p 100 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |